Chaoyue Chen
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1" [Bioorg. Chem. 151 (2024) 107700].
Journal: Bioorganic chemistry
Published: July 28, 2026
Discovery and Structural Optimization of Novel 2-Aminopyrimidine Derivatives as Potent and Selective IKKβ Inhibitors for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: December 02, 2025
Anticancer and chemo-sensitizing effects of annonacin via p53-mediated DNA damage in ovarian cancer.
Anticancer and chemo-sensitizing effects of annonacin via p53-mediated DNA damage in ovarian cancer.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 18, 2025
Discovery of Novel 2,4,5-Trisubstituted Pyrimidine Derivatives as Potent and Selective FGFR Inhibitors against Gatekeeper Mutants for the Treatment of NSCLC.
Journal: Journal of medicinal chemistry
Published: March 03, 2025
Harmine alleviates LPS-induced acute lung injury by inhibiting CSF3-mediated MAPK/NF-κB signaling pathway.
Journal: Respiratory research
Published: December 18, 2024
C1632 protects against LPS-induced acute lung injury by regulating AXL-mediated MAPK/NF-κB signaling pathway.
Journal: International immunopharmacology
Published: December 17, 2024
The potential biological function of STARD8 in prostate cancer: A bioinformatic and experimental validation study.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 18, 2024
Design, synthesis, and biological evaluation of Flavokavain B derivatives as potent TRF2 inhibitors for the treatment of Osteosarcoma.
Journal: European journal of medicinal chemistry
Published: September 16, 2024
Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1.
Journal: Bioorganic chemistry
Published: May 17, 2024
Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity.
Journal: Computational and structural biotechnology journal
Published: November 11, 2023
STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Journal: International immunopharmacology
Published: May 12, 2023
Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells.
Journal: Cell death discovery
Published: November 15, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026